Media headlines about Joint Corp (NASDAQ:JYNT) have been trending positive recently, according to AlphaOne. The research group, a service of Accern, identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real-time. AlphaOne ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Joint Corp earned a news impact score of 0.31 on AlphaOne’s scale. AlphaOne also assigned media coverage about the company an impact score of 0 out of 100, indicating that recent news coverage is extremely unlikely to have an effect on the stock’s share price in the near term.

JYNT has been the subject of a number of research reports. Zacks Investment Research cut shares of Joint Corp from a “hold” rating to a “sell” rating in a research note on Tuesday, April 4th. Feltl & Co. reissued a “buy” rating on shares of Joint Corp in a research note on Friday, March 10th. Finally, Maxim Group reissued a “buy” rating and issued a $7.00 price target (up previously from $5.00) on shares of Joint Corp in a research note on Friday, March 10th.

Joint Corp (NASDAQ:JYNT) remained flat at $3.75 during trading on Thursday. The company had a trading volume of 10 shares. Joint Corp has a 52 week low of $1.85 and a 52 week high of $4.74. The stock’s market capitalization is $48.95 million. The stock’s 50-day moving average is $3.84 and its 200-day moving average is $3.26.

Joint Corp (NASDAQ:JYNT) last released its quarterly earnings data on Thursday, March 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.03. The firm had revenue of $5.78 million for the quarter, compared to analysts’ expectations of $5.80 million. Joint Corp had a negative net margin of 69.13% and a negative return on equity of 78.74%. Analysts expect that Joint Corp will post ($0.32) EPS for the current fiscal year.

In related news, major shareholder Glenhill Advisors Llc sold 86,428 shares of the firm’s stock in a transaction on Tuesday, March 28th. The shares were sold at an average price of $3.40, for a total value of $293,855.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director James H. Amos, Jr. bought 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 29th. The stock was acquired at an average cost of $3.98 per share, with a total value of $39,800.00. Following the completion of the acquisition, the director now owns 29,345 shares of the company’s stock, valued at approximately $116,793.10. The disclosure for this purchase can be found here. Company insiders own 14.60% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was first reported by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at

About Joint Corp

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

5 Day Chart for NASDAQ:JYNT

Receive News & Ratings for Joint Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint Corp and related companies with's FREE daily email newsletter.